BioSig Technologies Equity 2024

BioSig Technologies Aktienanalyse

What does BioSig Technologies do?

Biosig Technologies Inc is a medical technology company based in New York, specializing in the development of advanced electrophysiological (EP) instruments and accessories for use in hospitals and clinics. The company was founded in 2009 and successfully went public in June 2018. The main task of Biosig Technologies is to provide doctors and medical professionals with helpful instruments that simplify the difficult work of EP tests and ablations. The development of EP instruments typically requires high specialization, as knowledge of both electrophysiology and engineering is required. However, Biosig has already gained a high level of expertise in this field and has established itself as a leading company in the industry. Biosig Technologies' business model is based on selling EP instruments and accessories to hospitals and clinics in the US and international markets. The products include the "PURE EP System," an electrophysiological signal processing and recording system specifically designed for use in EP tests and ablations. The "PURE EP System" allows doctors to obtain accurate information about the electrical activity of the heart in order to improve the diagnosis and treatment of cardiac arrhythmias. The "PURE EP System" has proven its excellence in practice and is successfully used by many clinics and hospitals in the US. The system offers higher sensitivity and accuracy than conventional electrophysiological instruments, enabling better differentiation and representation of signals originating from different heart tissues. This allows doctors to make more accurate diagnoses and develop more targeted treatment strategies. Biosig Technologies offers a wide range of products and services tailored to the needs of customers in various areas of healthcare. The company also provides excellent customer support and training to ensure that users properly utilize the instruments and maximize their benefits. In addition to the EP field, the company is also exploring the use of the technology in other areas of medicine. Biosig Technologies actively works on the development of instruments to improve respiratory monitoring and facilitate the use of robots in surgery. The company plans to bring more instruments and accessories to the market in the future to expand its portfolio and meet additional customer needs. Biosig Technologies is a dynamic company with a high degree of innovation and a strong focus on the needs of doctors and medical professionals. The company aims to improve healthcare by providing advanced instruments and accessories, making a positive contribution to society. BioSig Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing BioSig Technologies's Equity

BioSig Technologies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding BioSig Technologies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating BioSig Technologies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

BioSig Technologies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in BioSig Technologies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about BioSig Technologies Stock

What is the equity of BioSig Technologies this year?

BioSig Technologies has equity of -2.91 M USD this year.

What was the equity of BioSig Technologies compared to the previous year?

The equity of BioSig Technologies has increased/decreased by -796.89% decreased compared to the previous year.

What impact does a high equity have on investors of BioSig Technologies?

A high equity is advantageous for investors of BioSig Technologies as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of BioSig Technologies?

A low equity can be a risk for investors of BioSig Technologies, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of BioSig Technologies affect the company?

An increase in equity of BioSig Technologies can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of BioSig Technologies affect the company?

A reduction in equity of BioSig Technologies can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of BioSig Technologies?

Some factors that can affect the equity of BioSig Technologies include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of BioSig Technologies so important for investors?

The equity of BioSig Technologies is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can BioSig Technologies take to change the equity?

To change equity, BioSig Technologies can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does BioSig Technologies pay?

Over the past 12 months, BioSig Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioSig Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of BioSig Technologies?

The current dividend yield of BioSig Technologies is .

When does BioSig Technologies pay dividends?

BioSig Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioSig Technologies?

BioSig Technologies paid dividends every year for the past 0 years.

What is the dividend of BioSig Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioSig Technologies located?

BioSig Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von BioSig Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioSig Technologies from 6/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did BioSig Technologies pay the last dividend?

The last dividend was paid out on 6/19/2024.

What was the dividend of BioSig Technologies in the year 2023?

In the year 2023, BioSig Technologies distributed 0 USD as dividends.

In which currency does BioSig Technologies pay out the dividend?

The dividends of BioSig Technologies are distributed in USD.